These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15320941)

  • 41. Oxygen therapeutics: can we tame haemoglobin?
    Alayash AI
    Nat Rev Drug Discov; 2004 Feb; 3(2):152-9. PubMed ID: 15043006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased viscosity of hemoglobin-based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes.
    Sakai H; Okuda N; Takeoka S; Tsuchida E
    Microvasc Res; 2011 Mar; 81(2):169-76. PubMed ID: 21167845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemospan: design principles for a new class of oxygen therapeutic.
    Vandegriff KD; Winslow RM
    Artif Organs; 2009 Feb; 33(2):133-8. PubMed ID: 19178457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood substitutes.
    Palmer AF; Intaglietta M
    Annu Rev Biomed Eng; 2014 Jul; 16():77-101. PubMed ID: 24819476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.
    Simons M; Gretton S; Silkstone GGA; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Leiva-Eriksson N; Ronda L; Mozzarelli A; Strader MB; Alayash AI; Reeder BJ; Cooper CE
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current aspects in red blood cell substitutes].
    Wang Y; Pan J; Yu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modified haemoglobins as oxygen-transporting blood substitutes.
    Mallick A; Bodenham AR
    Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The development of polymerized pyridoxylated hemoglobin solution as a red cell substitute.
    Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS
    Ann Emerg Med; 1986 Dec; 15(12):1416-9. PubMed ID: 3777613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
    Samaja M; Malavalli A; Vandegriff KD
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood substitutes and redox responses in the microcirculation.
    Baldwin AL
    Antioxid Redox Signal; 2004 Dec; 6(6):1019-30. PubMed ID: 15548899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant hemoglobins as artificial oxygen carriers.
    Fronticelli C; Koehler RC; Brinigar WS
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):45-52. PubMed ID: 17364470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemoglobin solutions.
    Creteur J; Vincent JL
    Crit Care Med; 2003 Dec; 31(12 Suppl):S698-707. PubMed ID: 14724468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel hemoglobin particles--promising new-generation hemoglobin-based oxygen carriers.
    Bäumler H; Xiong Y; Liu ZZ; Patzak A; Georgieva R
    Artif Organs; 2014 Aug; 38(8):708-14. PubMed ID: 24962099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reviving artificial blood: meeting the challenge of dealing with NO scavenging by hemoglobin.
    Lui FE; Kluger R
    Chembiochem; 2010 Sep; 11(13):1816-24. PubMed ID: 20661989
    [No Abstract]   [Full Text] [Related]  

  • 58. Reconstructing hemoglobin-based oxygen carriers.
    Greenburg AG; Light WR; Dubé GP
    Transfusion; 2010 Dec; 50(12):2764-7; author reply 2767. PubMed ID: 21126254
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of neo red cells (NRC) with the enzymatic reduction system of methemoglobin.
    Ogata Y; Goto H; Kimura T; Fukui H
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):417-27. PubMed ID: 9242936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.